{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T09:10:01Z","timestamp":1756285801750,"version":"3.44.0"},"reference-count":27,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2019,9,6]]},"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>A 20-year-old college student presented with high grade, intermittent fever for 10 days associated with blood stained loose stools after taking tablet levamisole for 17 days for vitiligo vulgaris. He was febrile, had a toxic appearance and appeared pale. Investigations showed neutropaenia with thrombocytopaenia. Blood cultures were sterile and stool cultures did not grow any enteric pathogens. His bone marrow examination was suggestive of an aplastic anaemia. He was administered empirical antibiotics, granulocyte colony stimulating factor and platelet transfusions. However, his fever and blood stained stools persisted. A repeat bone marrow examination after 2\u2009weeks still revealed a hypoplastic marrow. Hence, a diagnosis of a levamisole induced bone marrow failure was made. While being worked up for an allogeneic stem cell transplantation, he developed neutropaenic enterocolitis and refractory septic shock with carbapenem resistant <jats:italic>Klebsiella pneumoniae<\/jats:italic> and succumbed to his illness.<\/jats:p>","DOI":"10.1136\/bcr-2019-231167","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T19:57:52Z","timestamp":1569873472000},"page":"e231167","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["A fatal case of levamisole induced bone marrow failure"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5405-8289","authenticated-orcid":false,"given":"John Titus","family":"George","sequence":"first","affiliation":[{"name":"Department of General Medicine, Christian Medical College and Hospital Vellore, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asisha M","family":"Janeela","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Christian Medical College and Hospital Vellore, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elanthenral","family":"Sigamani","sequence":"additional","affiliation":[{"name":"Department of Pathology, Christian Medical College and Hospital Vellore, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2769-1211","authenticated-orcid":false,"given":"Alice Joan","family":"Mathuram","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Christian Medical College and Hospital Vellore, Vellore, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2019,9,30]]},"reference":[{"key":"2025082701350739000_12.9.e231167.1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1182\/blood.V56.3.388.388","article-title":"Studies on levamisole--induced agranulocytosis","volume":"56","author":"Thompson","year":"1980","journal-title":"Blood"},{"key":"2025082701350739000_12.9.e231167.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2012.03.010"},{"key":"2025082701350739000_12.9.e231167.3","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s00204-017-1947-4","article-title":"Adverse effects of levamisole in cocaine users: a review and risk assessment","volume":"91","author":"Brunt","year":"2017","journal-title":"Arch Toxicol"},{"key":"2025082701350739000_12.9.e231167.4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2011.06.105"},{"key":"2025082701350739000_12.9.e231167.5","doi-asserted-by":"publisher","DOI":"10.1097\/MOH.0b013e32834da9ef"},{"key":"2025082701350739000_12.9.e231167.6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0378-6323.175927","article-title":"Levamisole: A multi-faceted drug in dermatology","volume":"82","author":"Gupta","year":"2016","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2025082701350739000_12.9.e231167.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02833.x"},{"key":"2025082701350739000_12.9.e231167.8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(76)90133-1","article-title":"Letter: Leucocytotoxic effect of levamisole","volume":"1","author":"Rosenthal","year":"1976","journal-title":"Lancet"},{"key":"2025082701350739000_12.9.e231167.9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0140-6736(77)92386-8","article-title":"Complications of cancer immunotherapy with levamisole","volume":"1","author":"Parkinson","year":"1977","journal-title":"Lancet"},{"key":"2025082701350739000_12.9.e231167.10","first-page":"77","article-title":"A study of the hematological side effects of levamisole in rheumatoid arthritis with recommendations","volume":"4","author":"Mielants","year":"1978","journal-title":"J Rheumatol Suppl"},{"key":"2025082701350739000_12.9.e231167.11","article-title":"Agranulocytosis \u2013 sequelae of chronic cocaine use: case series and literature review","volume":"9","author":"Srivastava","year":"2017","journal-title":"Cureus"},{"key":"2025082701350739000_12.9.e231167.12","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/0167-5699(90)90109-M","article-title":"HLA-B27 and agranulocytosis by levamisole","volume":"11","author":"Diez","year":"1990","journal-title":"Immunol Today"},{"key":"2025082701350739000_12.9.e231167.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2011.04.010"},{"key":"2025082701350739000_12.9.e231167.14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.12659\/AJCR.903917","article-title":"Levamisole-induced leukocytoclastic vasculitis with negative serology in a cocaine user","volume":"18","author":"Salehi","year":"2017","journal-title":"Am J Case Rep"},{"key":"2025082701350739000_12.9.e231167.15","first-page":"1721","article-title":"Adverse reactions to levamisole","volume":"62","author":"Symoens","year":"1978","journal-title":"Cancer Treat Rep"},{"key":"2025082701350739000_12.9.e231167.16","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S0140-6736(77)90918-7","article-title":"Neurological complication of levamisole","volume":"2","author":"Sigidin","year":"1977","journal-title":"Lancet"},{"key":"2025082701350739000_12.9.e231167.17","first-page":"171","article-title":"[Levamisole induced agranulocytosis and thrombocytopenia]","volume":"142","author":"Nielsen","year":"1980","journal-title":"Ugeskr Laeger"},{"key":"2025082701350739000_12.9.e231167.18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/mpo.2950240409","article-title":"Reversible thrombocytopenia with levamisole","volume":"24","author":"Winquist","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"2025082701350739000_12.9.e231167.19","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1097\/00007611-198207000-00041","article-title":"Thromboneutropenia and levamisole","volume":"75","author":"Andes","year":"1982","journal-title":"South Med J"},{"key":"2025082701350739000_12.9.e231167.20","first-page":"1","article-title":"Levamisole\/cocaine induced systemic vasculitis and immune complex glomerulonephritis","volume":"2015","author":"Garg","year":"2015","journal-title":"Case Rep Nephrol"},{"key":"2025082701350739000_12.9.e231167.21","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-015-0279-z"},{"key":"2025082701350739000_12.9.e231167.22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jflm.2013.10.015","article-title":"Acute coronary syndrome after levamisole-adultered cocaine abuse","volume":"21","author":"Michaud","year":"2014","journal-title":"J Forensic Leg Med"},{"key":"2025082701350739000_12.9.e231167.23","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1553-2712.2011.01202.x","article-title":"Levamisole exposure and hematologic indices in cocaine users","volume":"18","author":"Chai","year":"2011","journal-title":"Acad Emerg Med"},{"key":"2025082701350739000_12.9.e231167.24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.39.1.59"},{"key":"2025082701350739000_12.9.e231167.25","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.112.045021"},{"key":"2025082701350739000_12.9.e231167.26","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000370097","article-title":"Cyclosporine combined with levamisole for lower-risk myelodysplastic syndromes","volume":"134","author":"Li","year":"2015","journal-title":"Acta Haematol"},{"key":"2025082701350739000_12.9.e231167.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1764-7"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2019-231167","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:35:18Z","timestamp":1756283718000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2019-231167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":27,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2019,9,30]]},"published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1136\/bcr-2019-231167"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2019-231167","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}